BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4880236)

  • 1. [Character of the effect of nalidixic acid (negram) on Escherichia coli strain 613].
    Planel'es KhKh; Andreeva AM; Moroz AF
    Antibiotiki; 1968 Jul; 13(7):617-20. PubMed ID: 4880236
    [No Abstract]   [Full Text] [Related]  

  • 2. [Resistance to nalidixic acid in tetracycline-resistant mutants of E. coli].
    Khanina MF; Gromova TG; Terekhov AA
    Antibiotiki; 1975; 20(12):1099-104. PubMed ID: 773284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity of an E. coli strain during therapy of experimental pyelonephritis using nalidixic acid].
    Hatala M; Ritzerfeld W; Prát V; Konícková L; Losse H
    Cas Lek Cesk; 1970 Mar; 109(14):291-6. PubMed ID: 4909024
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antimicrobial action of nalidixic acid and the effect on the elimination of resident drug-resistant Shigella and E. coli in mice].
    Ogasawara K; Ata S; Kasuya M; Kobayashi T
    Igaku To Seibutsugaku; 1965 Jun; 70(6):343-8. PubMed ID: 5318841
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of nalidixic acid activity on 3186 strains of Gram negative bacilli. Application to the treatment of urinary infections].
    Chamfeuil R; Curcier H
    Presse Med (1893); 1969 Nov; 77(48):1763-4. PubMed ID: 4903534
    [No Abstract]   [Full Text] [Related]  

  • 6. [Simplified method for conjugational transference of R factors on solid culture media].
    Tiagunenko IuV
    Antibiotiki; 1971 Feb; 16(2):158-62. PubMed ID: 4934036
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of nalidixic acid on Escherichia coli growth in milk.
    Tyczyńska B; Bassalik-Chabielska L
    Acta Microbiol Pol; 1987; 36(3):221-7. PubMed ID: 2447751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of the action of nalidixic acid on the submicroscoic structure of bacteria].
    Kats LN; Andreeva AM; Moroz AF
    Antibiotiki; 1968 Sep; 13(9):841-5. PubMed ID: 4884476
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutation affecting resistance of Escherichia coli K12 to nalidixic acid.
    Hrebenda J; Heleszko H; Brzostek K; Bielecki J
    J Gen Microbiol; 1985 Sep; 131(9):2285-92. PubMed ID: 3906038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro sensitivity pattern of gram negative pathogens to nalidixic acid.
    Chitkara YK
    Indian J Pathol Bacteriol; 1969 Oct; 12(4):162-8. PubMed ID: 4990210
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of R-factor on E.coli sensitivity to ultraviolet and -radiation].
    Gromova TG; Moraz AF
    Antibiotiki; 1971 Nov; 16(11):995-8. PubMed ID: 4947973
    [No Abstract]   [Full Text] [Related]  

  • 12. Types of spontaneous nalidixic acid resistant mutants of Escherichia coli.
    Kumar S
    Indian J Exp Biol; 1980 Apr; 18(4):341-3. PubMed ID: 6995285
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of some antitumor chemotherapeutic preparations on the transfer of the episome determinant of resistance in enterobacterial].
    Smolianskaia AZ
    Mikrobiologiia; 1970; 39(5):882-6. PubMed ID: 4925039
    [No Abstract]   [Full Text] [Related]  

  • 14. Nalidixic acid-resistant auxotrophs of Escherichia coli.
    Helling RB; Adams BS
    J Bacteriol; 1970 Nov; 104(2):1027-9. PubMed ID: 4923064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal competitive exclusion of salmonella and Escherichia coli by native intestinal microflora of the chicken and turkey.
    Weinack OM; Snoeyenbos GH; Smyser CF; Soerjadi AS
    Avian Dis; 1982; 26(3):585-95. PubMed ID: 6756372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are quinolone-resistant uropathogenic Escherichia coli less virulent?
    Vila J; Simon K; Ruiz J; Horcajada JP; Velasco M; Barranco M; Moreno A; Mensa J
    J Infect Dis; 2002 Oct; 186(7):1039-42. PubMed ID: 12232848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
    Cattoir V; Lesprit P; Lascols C; Denamur E; Legrand P; Soussy CJ; Cambau E
    J Antimicrob Chemother; 2006 Nov; 58(5):1054-7. PubMed ID: 16984897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial effect of nalidixic acid in experimental acute Escherichia coli pyelonephritis].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Arztl Forsch; 1968 Feb; 22(2):69-72. PubMed ID: 4876157
    [No Abstract]   [Full Text] [Related]  

  • 19. Nalidixic acd-resistant mutants of Escherichia coli deficient in isocitrate dehydrogenase.
    Helling RB; Kukora JS
    J Bacteriol; 1971 Mar; 105(3):1224-6. PubMed ID: 4926678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DNA content in Escherichia coli mutants resistant to rifampicin and nalidixic acid].
    Korotiaev AI; Krolichenko TP
    Mikrobiologiia; 1982; 51(6):983-5. PubMed ID: 6759888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.